RGXTF yields 10582.01% · PFE yields 6.13%● Live data
📍 RGXTF pulled ahead of the other in Year 1
Combined, RGXTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGXTF + PFE for your $10,000?
Regenx Tech Corp. engages in the exploration and development of mineral properties, and the development and deployment of extraction technologies in Spain and North America. The company has an option acquire interest in the Aroche Wollastonite Project that consists of five mining grids covering approximately 150 hectares located in the province of Huelva, southwestern Spain. It also develops HM X-mill, a mineral grinding mill for grinding of ores, as well as regrinding of concentrates and tailings; HM X-leach, a cyanide-free process for the extraction of gold and other precious metals; and HM X-tract, a modular turnkey portable processing unit that includes crushing, grinding, sizing, gravity separation, floatation, concentration, clarification, water recycling, power generation, and operational service support modules. The company was formerly known as Mineworx Technologies Ltd. and changed its name to Regenx Tech Corp. in October 2022. Regenx Tech Corp. was incorporated in 2017 and is based in St. Albert, Canada.
Full RGXTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.